Ocular Therapeutix
Biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye.
Launch date
Employees
Market cap
€1.3b
Enterprise valuation
€927m (Public information from Sep 2024)
Share price
$9.04 OCUL
Bedford Texas (HQ)
Authorizing premium user...